Tag: vaccines

Vaccinations: The Superheroes of Childhood Development

Vaccinations are often hailed as one of the greatest medical achievements of modern civilization. They protect against life-threatening diseases and pave the way for children to grow into healthy, thriving adults. This blog delves into the multifaceted benefits of vaccinations on childhood development, highlighting their role beyond merely preventing illness.

Building a Foundation for Healthy Growth

The primary role of vaccinations is to safeguard children from various infectious diseases, ranging from measles and mumps to whooping cough and influenza. By preventing these illnesses, vaccines lay the groundwork for children to enjoy a healthier childhood. The Centers for Disease Control and Prevention (CDC) offers a comprehensive list of diseases preventable by childhood vaccinations, emphasizing the critical role these vaccines play in early life health.

Supporting Educational Success

Frequent illnesses can lead to missed school days, hindering a child’s learning and social development. Vaccinations reduce the incidence of vaccine-preventable diseases, thereby minimizing absences from school. A study published in the Journal of Infectious Diseases highlights the correlation between vaccination and reduced absenteeism in educational settings. Children vaccinated according to the recommended schedule are more likely to attend school regularly, participating fully in academic and extracurricular activities crucial for cognitive and social growth.

Enhancing Social Interaction

Social interaction is vital to children’s emotional intelligence and interpersonal skills. Illnesses can isolate children, preventing them from engaging in play and interaction with their peers. Vaccinations enable children to participate in group activities without the constant threat of catching or spreading infectious diseases. The American Academy of Pediatrics underscores the importance of vaccinations in ensuring that children can safely engage in social activities essential for their emotional and psychological well-being.

Economic Impact on Families

The economic burden of managing vaccine-preventable diseases can be significant for families. Vaccinations help reduce medical costs by preventing illnesses that require hospitalization and long-term care. The World Health Organization (WHO) discusses the economic benefits of immunization, highlighting how vaccines reduce healthcare expenses, thus easing financial pressures on families and allowing for better resource allocation towards education and development.

Vaccinations are indeed the unsung heroes of childhood development. They shield against various diseases while supporting children’s overall growth and well-being. By fostering a healthier, more inclusive environment for learning and social interaction, vaccinations contribute significantly to the foundation upon which children can build their futures. As parents and guardians, ensuring that our children receive their vaccinations on schedule is one of the most effective ways to give them a leg up.

In an era when misinformation about vaccines can be prevalent, it’s crucial to rely on credible sources and healthcare professionals for guidance. Vaccinations have been and continue to be a cornerstone of public health, safeguarding not just individual children but entire communities and enabling the next generation to grow healthier, smarter, and stronger.

Sources:

CDC: www.cdc.gov/vaccines

APP: https://www.aap.org/

WHO: https://www.who.int/

FAQs: Essential Travel Vaccination Guide: Protecting Your Health Globally

1. Why are vaccinations important for travel?

Vaccinations are critical to protect you from common infectious diseases in areas you plan to visit. They act as a protective barrier, and failure to receive them can expose you to illnesses that could ruin your trip or pose severe health risks. Vaccinations also help prevent the transfer of diseases between nations, contributing to global health security.

2. What are some common diseases travelers may encounter?

Travelers can encounter a range of diseases uncommon in their home countries. These include Hepatitis A, contracted through contaminated food or water, Typhoid fever, Yellow fever, and Malaria, mosquito-borne diseases common in tropical regions. Less familiar but serious diseases include Rabies and Japanese encephalitis, prevalent in certain regions.

3. How can I know which vaccinations are necessary for my travel destination?

Each destination has its unique set of required or recommended vaccinations. You should evaluate health guidelines for your travel destinations well before your trip. Websites like the Centers for Disease Control and Prevention (CDC) provide updated information about location-specific vaccines and health guidelines. You can also consult your healthcare provider or a travel medicine specialist.

4. Are there any universal vaccinations that all travelers should consider?

Regardless of your destination, every traveler should consider several universally relevant vaccinations. These include updates to routine vaccinations like measles-mumps-rubella (MMR), diphtheria-tetanus-pertussis (DTP), and influenza. Hepatitis A vaccine is recommended for most travelers due to its global prevalence and ease of transmission.

5. When should I get my travel vaccinations?

Many vaccines require multiple doses administered weeks or months apart, with full immunity achieved only weeks after the final dose. Therefore, you should plan your vaccinations well before your departure, ideally starting the process four to six weeks before traveling.

6. How can I keep track of my vaccination records?

Maintaining an accurate record of your vaccinations is crucial. These records prove your immunizations; some countries might require them upon arrival. Ensure that you carry an official immunization record card and secure electronic copies, either emailed or stored in a secured cloud service, with photos of these documents as a backup.

7. Do I need to fill out any forms for my vaccinations?

Certain countries might require a healthcare professional to complete specific forms, such as the International Certificate of Vaccination or Prophylaxis (ICVP) for yellow fever. Make sure these forms are correctly filled and stored alongside your passport.

8. What happens if I don’t get vaccinated before my trip?

Not getting vaccinated leaves you susceptible to illnesses that could spoil your journey or pose serious health threats. It also increases the risk of transferring diseases between nations, undermining global health security.

9. Can I still get vaccinated if I have last-minute travel plans?

If you’re making last-minute travel plans, immediately consult with a healthcare provider about vaccines that can still provide some protection. Some protection greatly outweighs none when averting illness overseas.

10. What if I can’t remember if I’ve had certain vaccinations?

Consult with your healthcare provider if you’re unsure about your vaccination history. They can help determine what vaccinations you may need. It’s always better to be safe and ensure your immunization record is current before setting off on your travels.

11. Do I need to vaccinate if I only travel to developed countries?

Yes, even when traveling to developed countries, it’s recommended to have your routine vaccinations up-to-date. Diseases like measles, mumps, rubella, and influenza are common in many parts of the world.

12. I had these vaccinations as a child. Do I need to take them again?

Some vaccinations given during childhood may require booster shots for ongoing protection. Consult with a healthcare provider to ensure your immunization record is current.

13. Are travel vaccinations safe?

Yes, travel vaccinations are safe. They have been thoroughly tested before approval, and serious side effects are rare.

14. Are there any side effects of travel vaccinations?

Common side effects are usually mild and go away on their own. They include pain and swelling at the injection site, mild fever, or feeling unwell. Serious side effects are rare.

15. Can I travel without vaccinations?

While it’s possible to travel without vaccinations, it’s not recommended. Vaccinations protect you from serious diseases and help prevent their spread.

16. Do I need to carry my vaccination records while traveling?

Yes, it’s important to carry your vaccination records while traveling. Some countries may require them upon arrival.

17. Can I take other medications with my travel vaccinations?

Generally, it’s safe to take other medications with travel vaccinations. However, you should always consult your healthcare provider.

18. Are there any people who should not get certain travel vaccinations?

Some people may be advised not to get certain vaccines due to their age, health conditions, or because they are pregnant. Always consult with your healthcare provider.

19. Can I get a travel vaccination if I am pregnant?

Some travel vaccines are safe if you’re pregnant, while others are not recommended. Consult with your healthcare provider.

20. If I got vaccinated before travel last year, do I need to do it again this year?

Some vaccines provide long-term protection, while others may need to be updated regularly. Check with your healthcare provider to see if you need booster shots or new vaccines.

Recent Studies Shed Light on Vaccine Safety and Myocarditis Concerns

The analysis showed people infected with COVID-19 before receiving a vaccine were 11 times more likely to develop myocarditis within 28 days of testing positive for the virus.

Misinformation about the safety of COVID-19 vaccines has spread like wildfire on social media and has contributed to a rise in vaccine hesitancy. Myocarditis, an inflammation of the heart muscle that can cause scarring but is usually resolved within days, has been at the center of these concerns. Recent studies have provided more insight into why more cases of heart inflammation have been reported.

COVID-19 Infection vs. Vaccination

A comprehensive study in England, detailed in the American Heart Association Journal Circulation, analyzed data from nearly 43 million individuals who had received COVID-19 vaccines between December 2020 and December 2021. The findings revealed that the risk of myocarditis following COVID-19 infection was substantially higher than that following vaccination.

The analysis showed people infected with COVID-19 before receiving a vaccine were 11 times more likely to develop myocarditis within 28 days of testing positive for the virus. However, this risk was halved if a person was infected after receiving at least one dose of the COVID-19 vaccine.

The analysis also looked at vaccine types. It showed that the risk for myocarditis increased after receiving the first dose of the AstraZeneca vaccine and after a first, second, and booster dose of the Pfizer or Moderna vaccine. The risk was still lower than exposure to COVID-19 infection before or after vaccination.

Yale Study Reveals Immune Causes of Post-Vaccination Myocarditis

A parallel study conducted by scientists at Yale University investigated the immune signatures of myocarditis cases observed post-vaccination. This study, published in the Journal of Science Immunology, provided insights into the underlying mechanisms triggering heart inflammation.

The Yale research team identified a more generalized immune response involving immune cells and inflammation as the culprits behind myocarditis. The immune systems of affected individuals exhibited an overproduction of cytokine and cellular responses, leading to heightened inflammation in heart tissue.

Implications From Both Studies

These findings are an important step towards providing the right recommendations on the vaccines certain individuals should receive, helping to shape public policy. While acknowledging the rare occurrence of myocarditis post-vaccination, it is crucial to contextualize the risks and benefits of COVID-19 vaccination in preventing severe illness and mortality.

According to the Centers for Disease Control and Prevention (CDC), among males aged 12 to 17, about 22 to 36 per 100,000 experienced myocarditis within 21 days after receiving a second vaccine dose. The incidence of myocarditis was 50.1 to 64.9 cases per 100,000 after infection with the COVID-19 virus among males in this age group.

Understanding the demographics at higher risk for myocarditis and the associated vaccine types can help create targeted vaccination approaches. For instance, recommendations regarding vaccine types for younger populations, particularly men under 40, may warrant reconsideration based on risk profiles outlined in the studies.

Also, the information these studies provide can pave the way for optimizing vaccine formulations to minimize adverse reactions while maximizing efficacy. The potential to enhance mRNA vaccines shows their broader utility beyond the pandemic.

The information is vital to understand to combat misinformation that spreads on social media and to eliminate growing vaccine hesitancy not only for COVID-19 but vaccines in general. The more these barriers are broken, the better we can respond to harmful diseases and future pandemics.

. . .

Sources:

Yale University study: Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditis

American Heart Association Journal Circulation: Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex

CDC: Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022

HPV Vaccination Rates Among Children

Research reveals that approximately 38.6% of children aged 9 to 17 in the United States had received at least one dose of the HPV vaccine by 2022.

The Human Papillomavirus vaccine has been around for two decades, but despite its availability and protectiveness against cervical cancer, it remains a vaccine many Americans are not getting.

HPV is the most common sexually transmitted infection (STI) worldwide. While most infections can clear up on their own within two years, some types of HPV can cause warts on various parts of the body, while others are associated with various cancers.

Recent data from the Centers for Disease Control and Prevention sheds light on vaccination rates and critical factors influencing uptake. Research reveals that approximately 38.6% of children aged 9 to 17 in the United States had received at least one dose of the HPV vaccine by 2022. Uptake increased with age, from 7.3% at age 9 to 10 years to 30.9% at age 11 to 12, 48.8% at age 13 to 14, and 56.9% at age 15 to 17.

Vaccine coverage remains low in the U.S., with findings revealing notable differences in vaccination rates among different demographics. Children covered by private health insurance were more likely to have higher vaccination rates, with 41.5% having received at least one dose, compared to 37% among those with Medicaid coverage and 20.7% among the uninsured.

The geographical aspect also played a role in vaccination rates. Those living in metropolitan areas had higher vaccination rates than those in nonmetropolitan regions. For instance, children in large central urban areas had a vaccination rate of 39.4%.

What’s Behind Low Uptake

There are other reasons why HPV vaccinations have stalled, with the most frequent cause being parents citing safety concerns. Each HPV vaccine has undergone strict safety testing before the U.S. Food and Drug Administration (FDA) licenses it. For the last 15 years, the HPV vaccine has continued to be monitored and researched, with each year showing that the vaccine is safe. Doctors urge parents to get their kids vaccinated with HPV before they become sexually active, which can also deter parents from scheduling an appointment. Regardless of the reason, discussing issues with your healthcare provider can help eliminate any concerns or questions you may have about vaccines.

There are minor side effects that can occur after receiving an HPV vaccine, like any medicine. Swelling, fever, dizziness, nausea, and joint pain are mild side effects that tend to clear up within 1 to 2 days.

When to get vaccinated

It’s recommended that HPV vaccination should be given to those aged 11–12 years. Vaccination is recommended to start as early as age 9 and continue up to age 26 for females and up to age 21 for males who have not completed the vaccine series previously. HPV vaccination can be recommended for individuals aged 27–45 years who have not been adequately vaccinated.

How HPV Infection Leads to Cancer

With more than 42 million Americans infected with types of HPV each year, it remains the most common disease out there. nearly everyone will be transmitted the virus at some point, which can linger in the immune system and turn normal cells into abnormal cells and then cancer. About 10% of women with HPV infection on their cervix will develop long-lasting HPV infections that put them at risk for cervical cancer.

The Importance of Getting Vaccinated

Since its introduction, the HPV vaccine has significantly reduced cancer-causing infections and precancers. This vaccination has helped the United States see a decrease of 88% in HPV-related cancers and genital warts in teenage girls, and 81% in adults. These findings underscore the importance of vaccinations in reducing the risk of life-altering diseases.

. . .

Sources

Centers for Disease Control and Prevention: National Center for Health Statistics

Centers for Disease Control and Prevention: Human Papillomavirus (HPV)

The Lancet Regional Health: Factors associated with parental human papillomavirus vaccination intentions among adolescents from socioeconomically advantaged versus deprived households: a nationwide, cross-sectional survey

Combating Myths: The Critical Fight Against Vaccine Hesitancy and Measles Outbreaks

Vaccine hesitancy has become a growing concern worldwide, with a noticeable impact on public health. As more parents succumb to misinformation and baseless claims about the dangers of childhood vaccines, we are witnessing a distressing rise in preventable diseases, particularly measles outbreaks.

The Rise of Vaccine Hesitancy

Vaccine hesitancy refers to the delay in acceptance or refusal of vaccines despite the availability of vaccination services. This phenomenon is not new, but it has gained momentum in recent years, fueled by misinformation spread through social media and specific groups claiming vaccines cause more harm than good. Despite overwhelming scientific evidence to the contrary, these claims have led too many parents to make decisions that endanger not only their children’s health but also public health at large.

The Impact on Measles Outbreaks

Measles is a highly contagious disease that can lead to severe health complications, including pneumonia, encephalitis, and death. The disease had been primarily controlled in many parts of the world thanks to widespread vaccination efforts. However, the growing vaccine hesitancy has led to declining vaccination rates, falling below the threshold needed to maintain herd immunity. As a result, we have seen a resurgence of measles outbreaks in various countries, affecting populations that were once protected.

The Dangers of Misinformation

The heart of the vaccine hesitancy problem lies in the spread of misinformation. Bogus claims, such as the debunked theory linking vaccines to autism, continue to circulate and find new audiences. This misinformation not only undermines the efforts of health professionals but also erodes public trust in one of the most effective tools we have for preventing disease. It is crucial to address and correct this misinformation, ensuring that parents and guardians have access to reliable, evidence-based information about the safety and efficacy of vaccines.

The Role of Public Health Initiatives

Combating vaccine hesitancy requires a concerted effort from public health officials, healthcare providers, and the media. Public health campaigns must actively reach out to hesitant parents, using clear, accessible, and persuasive messaging. Healthcare providers also play a critical role in this effort, as they are often the most trusted source of information for parents. By engaging in open, empathetic conversations with parents about their concerns, healthcare providers can help dispel myths and encourage vaccination.

The rise in vaccine hesitancy and the consequent measles outbreaks represent a significant public health challenge. It is a reminder of the importance of vaccination and the need to combat misinformation vigorously. As a society, we must prioritize the health and well-being of all individuals, particularly the most vulnerable among us. By doing so, we can ensure that diseases like measles remain a thing of the past rather than a recurring threat.

. . .

  • Vaccine hesitancy: The WHO describes vaccine hesitancy as a growing challenge for immunization programs worldwide, highlighting its complex nature and the variety of factors that contribute to it, such as misinformation, complacency, convenience, and confidence. Effective communication and tailored strategies are emphasized as key to improving vaccine acceptance​.
  • Vaccines and immunization: This section provides an overview of immunization’s role as a global health success story, noting that vaccines prevent 3.5–5 million deaths every year from diseases such as diphtheria, tetanus, pertussis, influenza, and measles. It also mentions the Immunization Agenda 2030, which aims to improve global vaccination coverage and ensure that everyone benefits from vaccines for good health and well-being​.

Study Reveals Effects of Maternal Flu Vaccination on Infants

Photo by TopSphere Media on Unsplash

The health and safety of your family is of the utmost importance, especially for first-time parents. Mothers want to feel confident when welcoming someone new into their family, and they can do that by maintaining their health. Vaccinations play a significant role in ensuring your newborn gets the best start in life. A recent study published in JAMA Pediatrics sheds light on the profound impact of maternal flu vaccination on the well-being of infants.

The study, conducted by the New Vaccine Surveillance Network Collaborators, resulted in findings regarding maternal flu vaccination and severe flu-related outcomes among infants younger than 6 months. Spanning multiple flu seasons from 2016 to 2020 across seven states, the research analyzed data from over 3,700 infants. The collected data provided valuable insights into the effectiveness of maternal flu vaccination.

One of the standouts of the study is the reduction in flu-related hospitalizations among infants born to vaccinated mothers. The research found there was a 39% lower risk compared to infants of unvaccinated mothers. Vaccine effectiveness was observed in various degrees, including a 34% reduction in overall severe outcomes, a 25% decrease in influenza A cases, and a 47% decline in influenza B infections among infants.

The study also found that vaccine effectiveness reached 53% among infants younger than 3 months, 52% among mothers vaccinated in the third trimester, and 17% among those whose mothers were vaccinated in the first or second trimester.

These findings spotlight the incredible connection between maternal vaccination and infant health. Pregnancy is notorious for weakening the immune system to support the growing baby. The body can consider the baby a biological invader because it shares genetic material from both parents. This results in a greater risk of catching something and getting sicker. Getting vaccinated not only shields the pregnant individual but also protects the developing fetus.

The timing of getting vaccinated is also crucial for the development and growth of the baby. The CDC recommends getting a flu vaccination in September or October. Consider early vaccination in July or August, especially in the third trimester. This schedule is similar to the Tetanus, Diphtheria, and Pertussis (Tdap) vaccine, which should be administered on the 27th to 36th week of pregnancy. The RSV vaccine is recommended on weeks 32 through 36 of pregnancy or during the baby’s first RSV season, which is optimal.

The study outlined clearly indicates the benefits of material vaccination during pregnancy. However, despite these facts, maternal vaccination coverage remains low globally. There are many factors to this; the leading cause is vaccine hesitancy among pregnant women. Most of the hesitancy is caused by myths and misinformation. Pregnant women should seek guidance and opinions from their doctor to ensure the correct information is relayed and they can address any concerns about vaccination. Getting vaccinated during pregnancy is pivotal in maintaining the health and safety of your family.

. . .

Sources:

Jama Network: Maternal Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department Visits in Infants

Centers for Disease Control and Prevention: Vaccines and Pregnancy: Things to Know

National Library of Medicine: Maternal vaccination — current status, challenges, and opportunities

Combatting Vaccine Fatigue: The Critical Role of Continued Immunizations

CDC data shows a drop from 173 million flu vaccinations in 2022 to just 155 million in 2023.

From COVID-19 to an intense flu season, there’s no doubt people are experiencing vaccine fatigue. Numbers provided by the Centers for Disease Control and Prevention show in 2022, 173 million Americans received flu vaccinations. This number recently dipped to 155 million in 2023. This decline in immunization is a national concern as pockets of outbreaks can happen, like most recently with measles. Understandably, people have felt exhausted in the past few years following the pandemic. However, it’s essential to understand why keeping up-to-date with your vaccines and new developments benefits your health.

Vaccine fatigue refers to the weariness and disillusionment individuals may experience regarding vaccines, particularly in prolonged or repeated vaccination campaigns. Recognizing that vaccine-preventable diseases extend far beyond a singular threat is essential. Diseases such as measles, polio, influenza, and HPV remain significant public health concerns, with vaccines helping to reduce their prevention. Vaccine fatigue can pose a threat to our public health as it can allow for pockets of these infections to spread, leaving the vulnerable populations exposed the most.

Continued immunization is also important for training the immune system to recognize and combat specific pathogens, such as viruses or bacteria. If you skip or avoid getting vaccinated, your immunity to certain diseases can wane, leaving you a target for getting sick. Maintaining a vaccine schedule also helps obtain herd immunity and protect young children from being immunocompromised. According to the CDC, 9 out of 10 people hospitalized with flu had at least one underlying health condition. This statistic reinforces the importance of making sure you’re thinking about not only your health but also the health of those around you.

There are a variety of strategies you can adopt to overcome vaccine fatigue. The latest vaccine information is from reliable sources such as the World Health Organization (WHO) or the CDC. You can also discuss any concerns about certain vaccines with your healthcare provider and learn more about their benefits and risks. Talking with friends and family, especially about vaccine fatigue, can alleviate isolation and reinforce your commitment to staying aware of sickness in your community.

Addressing vaccine fatigue requires a multifaceted approach that acknowledges the complex interplay of social, cultural, and economic factors influencing vaccination decisions. Education and understanding the benefits of vaccination may seem like a daunting task you can quickly get tired of. However, understanding the underlying factors contributing to fatigue will create a healthier community and prevent diseases.

. . .

Sources:

Centers for Disease Control and Prevention: Vaccines & Immunizations

Centers for Disease Control and Prevention: Vaccine Effectiveness: How Well Do Flu Vaccines Work

National Library of Medicine: Mind the “Vaccine Fatigue”

Protecting Children Against the Tripledemic Through Vaccination

We still have a way to go before the winter season ends, but there seems to be no end in sight to this cold and flu season. This year has been especially hard on families with RSV, COVID-19, and the flu, accompanied by the common cold, creating a perfect storm of illnesses. Three pediatric influenza-related deaths in Tennessee have been reported since the flu season began in October. According to the latest data from the Centers for Disease Control and Prevention (CDC), there have been 65 influenza-related pediatric deaths so far in the 2023–2024 flu season. This flu season has taken a toll on children, prompting a closer look at the importance of vaccination.

Getting Vaccinated:

Data collected by the CDC on last year’s flu season showed that 90% of the children who died were not fully vaccinated. Vaccines are our best means of fighting off severe flu complications. Children over six months must receive their vaccination during complicated influenza seasons like the one we see. Even if you have infants too young to be vaccinated, parents and caregivers can receive a vaccine, so there is a protection barrier between you and your child.

Recognizing the Different Illnesses:

With various respiratory illnesses circulating simultaneously, distinguishing RSV, the flu, and COVID-19, can be challenging. RSV commonly presents with respiratory distress, wheezing, and fever, primarily affecting infants and young children. The flu typically brings on a fever, cough, and body aches. COVID-19 symptoms in children may include fever, cough, and difficulty breathing, although they might be milder than in adults. The CDC has a list of symptoms you can review to help you distinguish between these illnesses and help mitigate the spread of contagious illnesses.

For infants and toddlers, recognizing flu symptoms can be trickier. Some signs your infant may be sick include trouble feeding or sleeping and changes in behavior. Severe symptoms that require immediate medical attention include a high fever persisting for days, trouble breathing, chest pain, signs of dehydration, severe headache, and continuous vomiting.

When to Get Vaccinated:

While getting vaccinated before the peak of the flu season is generally recommended, it’s never too late. The respiratory virus season can extend into March or even later. Additionally, COVID-19 vaccinations are available throughout the year, and vaccination against respiratory infections like RSV is beneficial regardless of the specific month. The effectiveness of vaccination can vary, but receiving the vaccine later in the season still provides valuable protection against severe illness, complications, and transmission of these viruses.

Steps to Ensure Everyone is Protected:

In addition to vaccination, adopting good health habits such as avoiding close contact with sick individuals, staying home when sick, covering coughs and sneezes, frequent handwashing, and avoiding touching the face can help prevent the spread of germs. Creating a routine around these preventive actions can help slow the spread of germs that can cause different illnesses. Adding this with vaccination can increase your chances of getting through this season happy and healthy.

With this tripledemic affecting the community, especially in Tennessee, protecting the youth from illness takes center stage. Vaccination significantly reduces the severity and impact of this cold and flu season. But it’s not the only measure to take. Parents and caregivers should also implement preventive measures and recognize early signs of symptoms to ensure children receive medical attention when needed.

. . .

Sources:

National Library of Medicine: Spatiotemporal variations of “triple-demic” outbreaks of respiratory infections in the United States in the post-COVID-19 era

Centers for Disease Control and Prevention: Protect yourself and others from Flu, COVID-19, and RSV

Centers for Disease Control and Prevention: Pediatric Flu Deaths Top 100 this Season; Most Unvaccinated

Centers for Disease Control and Prevention: Weekly U.S. Influenza Surveillance Report

Tennessee Influenza Report

The Significance of the Measles Vaccination for Children in Times of Resurgence

In the United States, there continue to be small outbreaks of the measles virus dispute the vaccine being readily available. Once on the brink of elimination, measles has made a comeback, posing a significant threat to children.

Measles is a highly contagious viral infection with symptoms resembling a common cold — fever, cough, runny nose, and red, watery eyes. A rash can occur that starts on the face and spreads across the body. Contracting measles in the U.S. results in hospitalization for approximately 1 in 5 individuals, and 1 to 3 out of 1,000 people with measles may die of the disease, even with the best medical attention.

According to the latest data from the Centers for Disease Control and Prevention, 48 cases of measles were reported by 20 jurisdictions. This number is lower than in previous years, but it’s concerning to see outbreaks occurring considering in the 2000s the disease was declared eliminated. Several factors contribute to this reintroduction, including international travel and reduced childhood vaccinations.

Vaccination remains the most effective way to combat the measles. Children should receive two doses of MMR (measles-mumps-rubella) vaccine, with the first dose starting between 12 and 15 months. The second dose should be administered to those 4 to 6 years old. The second dose can be given earlier just if it is 28 days after the first dose.

A single dose of the MMR vaccine is 93% effective against measles, 78% effective against mumps, and 97% effective against rubella. Two doses of MMR vaccine are 97% effective against measles and 88% effective against mumps. People receiving their MMR vaccinations are usually considered protected for life against measles and rubella.

One of the most significant challenges with this disease is a delay in accepting the vaccine. The controversy surrounding the link between the MMR vaccine and autism has been thoroughly investigated and debunked by extensive reports from the American Academy of Pediatrics, the National Academy of Medicine, and the CDC. These organizations have found that autism is often identified in those between 18 and 30 months of age, which is around the same time children are given their first MMR vaccine.

The recent resurgence of measles in the United States is a stark reminder of the importance of vaccination. This disease remains one of the leading causes of death among young children globally. While the risk of measles in the U.S. is low, if vaccination rates continue to decline the country could see larger pockets of outbreaks across different jurisdictions. By prioritizing vaccination, we can prevent this disease from spreading further and return to the conditions of the early 2000s when measles was successfully eradicated in the U.S.

. . .

Sources

Centers for Disease Control and Prevention: Measles (Rubeola)

Mayo Clinic: Measles

American Academy of Pediatrics: Vaccines — Autism Toolkit

National Academy of Medicine: Vaccines do not cause Autism

World Health Organization: Measles

Getting the HPV Vaccine During Cervical Cancer Awareness Month

January is Cervical Cancer Awareness Month (CCAM) and it’s an opportunity to raise awareness about the prevention and early intervention of one of the most common and preventable cancers in women.

Cervical cancer develops slowly over time and starts in the cells of the cervix. The cervix connects the upper part of the uterus and anyone with a cervix can develop cervical cancer. Most cases of cervical cancer are caused by persistent infection with high-risk types of human papillomavirus (HPV). HPV is a common sexually transmitted infection, and while most infections clear on their own, persistent infections can lead to cervical cancer over time. The body’s immune system typically prevents HPV from doing any harm, however, in a small percentage of people, the virus survives for years and contributes to the process that causes some cervical cells to become cancer cells.

In 2020, 11,542 new cases of cervical cancer were reported among women in the United States, and 4,272 women died of this cancer. Every day in Tennessee, a woman is diagnosed with cervical cancer, and every three days one dies from the disease. Globally, cervical cancer is in the top ten most common cancers in women, with 604,000 new cases recorded in 2020. About 90% of the 342,000 deaths caused by cervical cancer occurred in low- and middle-income countries.

Risk Factors:

Other risk factors can contribute to the development of cervical cancer, which include:

● HPV Infection: HPV is the primary cause of cervical cancer and is responsible for over 90% of diagnoses.

● Smoking: Tobacco use has been linked to an increased risk of cervical cancer.

● Long-term Use of Oral Contraceptives: Prolonged use of certain birth control pills may contribute to the risk.

Prevention:

While there is no guarantee to prevent cervical cancer, maintaining a healthy diet, exercising, routine screenings, and the HPV vaccine all help to reduce the risk. The Center for Disease Prevention and Control (CDC) Advisory Committee on Immunization Practices (ACIP) recommends beginning the HPV vaccine series as low as the age of 9 with the possibility of continuing from age 27 to 45.

Women should also seek screening for cervical cancer every 5–10 years starting at age 30. Screening includes cervical cytology (also called the Pap test or Pap smear) and testing for human papillomavirus (HPV). Getting routinely checked has been known to save lives, with the American College of Obstetricians and Gynecologistssaying the number of cervical cancer cases and deaths has decreased by one-half over the past 30 years.

Symptoms and Treatment:

Cervical cancer may not cause noticeable signs and symptoms in its early stages, which is why regular screening is important for early detection. As the cancer progresses, symptoms may become more apparent. Some common symptoms of cervical cancer include:

● Abnormal vaginal bleeding

● Pelvic pain

● Vaginal discharge

● Pain during urination

● Back pain or leg swelling

● Weight loss, fatigue, and loss of appetite

If cervical cancer develops, it’s often treated with surgery to remove the cancer. Other treatments can include chemotherapy or targeted therapy medicines to kill the cancer cells. Radiation therapy is also used along with low-dose chemotherapy.

A Global Call to Action:

The World Health Organization (WHO) has set out a global strategy to eliminate cervical cancer as a public health problem by 2120. To guide countries towards achieving this goal by 2030, three specific targets have been established:

● 90% of girls vaccinated with the HPV vaccine by age 15.

● 70% of women screened with a high-quality test by ages 35 and 45.

● 90% of women with cervical disease receiving treatment.

By achieving this goal, the WHO estimates that 74 million new cases of cervical cancer can be averted, and 62 million deaths can be avoided.

Cervical Cancer Awareness Month is a time to raise awareness about cervical cancer and get informed, get screened, and get vaccinated. Committing to this is not just a matter of health; it’s also a human right. Participating in Cervical Cancer Awareness Month contributes to the global effort to eradicate preventable diseases and promote a healthier, more equitable world.

. . .

Sources:

World Health Organization: Cervical Cancer Awareness Month 2023

Tenessee Health Department: Cervical Cancer Information and Screening Guidelines

Centers for Disease Control and Prevention: Cancer Statistics At a Glance

Centers for Disease Control and Prevention: Cervical Cancer

American College of Obstetricians and Gynecologists: Cervical Cancer Screening

Get the latest updates from Health Hero
Close